Are OPG and RANKL involved in human fracture healing?
| Autor: | Kambiz Sarahrudi, Julia Köttstorfer, Anita C Thomas, Markus Gregori, Mathias Kecht, Georg Kaiser, Stefan Eipeldauer |
|---|---|
| Rok vydání: | 2014 |
| Předmět: |
musculoskeletal diseases
medicine.medical_specialty biology business.industry Long bone Osteoblast Bone healing medicine.disease Pseudarthrosis medicine.anatomical_structure Endocrinology Hematoma Osteoprotegerin Osteoclast RANKL Internal medicine medicine biology.protein Orthopedics and Sports Medicine business |
| Zdroj: | Journal of Orthopaedic Research. 32:1557-1561 |
| ISSN: | 0736-0266 |
| Popis: | Human fracture healing is a complex interaction of several cytokines that regulate osteoblast and osteoclast activity. By monitoring OPG (osteoprotegerin) and sRANKL we aimed to possibly predict normal or impaired fracture healing. In 64 patients with a fracture of a long bone serum level of sRANKL and OPG were evaluated with respect to bony union (n=57) or pseudarthrosis (n=7). Measurements were carried out at admission and at 1, 2, 4, 6, 8, 12, 24, and 48 weeks after the injury. Patients' serum levels were compared to 33 healthy controls. Fracture hematoma contained significantly higher sRANKL and OPG concentrations compared to patients serum (p=0.005, p=0.028). OPG level in fracture hematoma was higher compared to the unions serum level (p=0.028). sRANKL was decreased in unions during the observation period. In non-unions sRANKL and OPG levels showed a variable course, with no statistical significance. This is the first study to document the course of OPG and sRANKL in normal and delayed human fracture healing emphasizing its local and systemic involvement. We provide evidence of strongly enhanced OPG levels in patients with a long bone fracture compared to healthy controls. Further, levels of free sRANKL were decreased during regular fracture repair. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Plný text